SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000905148-18-000769
Filing Date
2018-09-20
Accepted
2018-09-20 11:48:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 efc18-561_sc13d.htm SC 13D 117998
  Complete submission text file 0000905148-18-000769.txt   119739
Mailing Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016
Business Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016 9493506999
Bison Capital Acquisition Corp. (Subject) CIK: 0001697805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90028 | Film No.: 181078983
SIC: 6770 Blank Checks

Mailing Address SUITE 4202, K. WAH CENTRE 1010 MIDDLE HUAIHAI ROAD SHANGHAI F4 200031
Business Address SUITE 4202, K. WAH CENTRE 1010 MIDDLE HUAIHAI ROAD SHANGHAI F4 200031 86 21 3356 6182 8009
Xynomic Pharmaceuticals, Inc. (Filed by) CIK: 0001750456 (see all company filings)

IRS No.: 814849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D